Trial Profile
The comparison of Eldecalcitol and Alfacalcidol on early osteoporosis caused by Anastrozole / Letrozole for post-operative breast cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Alfacalcidol (Primary) ; Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- 29 Nov 2012 New trial record